Genetic Basis of Dilated Cardiomyopathy: Recent Evidence and Further Challenges
By: K. Vitanova, R. Tzveova, T. Yaneva-Sirakova, M. Shumkova, I. Dimova and R. Kaneva
References
- McNally EM, Mestroni L. Dilated Cardiomyopathy. Circulation Research. 2017 Sep 15;121(7):731-48. doi:10.1161/CIRCRESAHA.116.309396
- Eldemire R, Mestroni L, Taylor MRG. Genetics of Dilated Cardiomyopathy. Annual Review of Medicine. 2024 Jan 29;75(Volume 75, 2024):417-26. doi:10.1146/annurev-med-052422-020535
- Schultheiss HP, Fairweather D, Caforio ALP et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019 May 9;5(1):1-19. doi:10.1038/s41572-019-0084-1
- Nomura S. Genetic and non-genetic determinants of clinical phenotypes in cardiomyopathy. J Cardiol. 2019 Mar;73(3):187-90. doi:10.1016/j.jjcc.2018.11.001.
- De Paris V, Biondi F, Stolfo D et al. Pathophysiology. In: Sinagra G, Merlo M, Pinamonti B, editors. Dilated Cardiomyopathy: From Genetics to Clinical Management [Internet], Cham (CH): Springer; 2019 [cited 2025 Mar 4], Available from: http://www.ncbi.nlm.nih.gov/books/NBK553848/.
- Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. In: StatPearls [Internet], Treasure Island (FL): Stat- Pearls Publishing; 2025 [cited 2025 Mar 4], Available from: http://www.ncbi.nlm.nih.gov/books/NBK441911/.
- Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. The Lancet. 2017 Jul 22;390(10092):400-14. doi: 10.1016/S0140-6736(16)31713-5.
- Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. International Journal of Molecular Sciences. 2021 Jan;22(14):7722. doi:10.3390/ijms22147722
- Dilated cardiomyopathy: the complexity of a diverse genetic architecture | Nature Reviews Cardiology [Internet], [cited 2025 Mar 5], Available from: https://www.nature.com/articles/nrcardio.2013.105
- Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature. J Intern Med. 2019 Oct;286(4):362-72. doi: 10.1111 /joim.12944.
- Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population- based study in Olmsted County, Minnesota, 1975-1984. Circulation. 1989 Sep;80(3):564-72. doi:10.1161/01.dr.80.3.564.
- Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007 Aug;26(8):782-95. doi:10.1016/j.healun.2007.06.003.
- Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006 Oct 18;296(15): 1867-76. doi:10.1001/jama.296.15.1867.
- Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008 Jan;29(2):270-6. doi:10.1093/eurheartj/ehm342.
- Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006 Apr 11;113(14):1807-16. doi:10.1161/CIRCULATIONAHA. 106.174287
- Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. In: StatPearls [Internet] [Internet]. StatPearis Publishing; 2023 [cited 2025 Mar 5]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK441911/
- Chien KR. Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J Clin Invest. 2003 Jan;111(2):175-8. doi:10.1172/JCI17612
- Naso P, Falco L, Porcari A, et al. Epidemiology. In: Sinagra G, Merlo M, Pinamonti B, editors. Dilated Cardiomyopathy: From Genetics to Clinical Management [Internet], Cham (CH): Springer; 2019 [cited 2025 Mar 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK553847/
- British Heart Foundation [Internet], [cited 2025 Mar 5], Dilated cardiomyopathy (DCM). Available from: https://www.bhf.org.uk/informationsupport/conditions/dilated-cardiomyopathy
- Myers MC, Wang S, Zhong Y, et al. Prevalence of Genetically Associated Dilated Cardiomyopathy: A Systematic Literature Review and Meta-Analysis. Cardiology Research. 2024 Aug 15; 15(4):233. doi: 10.14740/cr.v0i0.1680
- Sweet ME, Taylor MR, Mestroni L. Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert Opinion on Orphan Drugs. 2015Aug 3;3(8):869-76. doi:10.1517/216 78707.2015.1057498
- Mestroni L, Brun F, Spezzacatene A, et al. Genetic causes of dilated cardiomyopathy. Progress in Pediatric Cardiology. 2014 Dec 1; Cardiomyopathy Part 1 - 201437(1):13-8. doi:10.1016/j.ppedcard.2014.10.003
- McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013 Jan;123(1):19-26. doi:10.1172/JCI62862
- Orphanou N, Papatheodorou E, Anastasakis A. Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments. Heart Fail Rev. 2022 Jul 1 ;27(4): 1173-91. doi:10.1007/s10741-021-10139-0
- Genetics of dilated cardiomyopathy - UpToDate [Internet], [cited 2025 Mar 6]. Available from: https://www.uptodate.com/contents/genetics-of-dilated-cardiomyopathy
- Voinescu OR, lonac A, Sosdean R, et al. Genotype-Phenotype Insights of Inherited Cardiomyopathies - A Review. Medicina. 2024 Apr;60(4):543. doi:10.3390/medicina60040543
- Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy | New England Journal of Medicine [Internet], [cited 2025 Mar 6], Available from: https://www.nejm.org/doi/full/10.1056/NEJM200012073432304
- Gigli M, Begay RL, Morea G, et al. A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies. Front Cardiovasc Med. 2016 Jul 21 ;3. doi:10.3389/fcvm.2016.00021
- Herman DS, Lam L, Taylor MRG, et al. Tnjncations of Titin Causing Dilated Cardiomyopathy. New England Journal of Medicine. 2012 Feb 16;366(7):619-28. doi:10.1056/NEJMoa1110186
- Hershberger RE, Jordan E. LMNA-Related Dilated Cardiomyopathy. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet], Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 Mar 6], Available from: http://www.ncbi.nlm.nih.gov/books/NBK1674/
- Dubik N, Mai S. Lamin A/C: Function in Normal and Tumor Cells. Cancers (Basel). 2020 Dec9;12(12):3688. doi:10.3390/cancers12123688.
- Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. JACC. 2016 Nov 29;68(21):2299-307. doi:10.1016/j.jacc.2016.08.058
- Pioner JM, Fornaro A, Coppini R, et al. Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy. Front Physiol. 2020 May 12;11. doi:10.3389/fphys.2020.00368
- Dungu JN, Langley SG, Hardy-Wallace A et al. Dilated cardiomyopathy: the role of genetics, highlighted in a family with Filamin C (FLNC) variant. Heart. 2022 May;108(9):676-82. doi:10.1136/heartjnl-2021-319682.
- Huang Y Shuo, Xing Y li, Li H Wtei. Heterozygous desmin gene (DES) mutation contributes to familial dilated cardiomyopathy. J Int Med Res. 2021 Apr 6;49(4):03000605211006598. doi:10.1177/03000605211006598.
- Dellefave L, McNally EM. The genetics of dilated cardiomyopathy. Cum Opin Cardiol. 2010 May;25(3): 198-204. doi: 10.1097/HCO.0b013e328337ba52.
- Hershberger RE, Parks SB, Kushner JD, et al. Coding Sequence Mutations Identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 Patients with Familial or Idiopathic Dilated Cardiomyopathy. Clinical and Translational Science. 2008; 1 (1 ):21-6. doi: 10.1111 /j.1752-8062.2008.00017.x
- Kraoua L, Louati A, Ahmed SB, et al. Homozygous TNNI3 frameshift variant in a consanguineous family with lethal infantile dilated cardiomyopathy. Mol Genet Genomic Med. 2024 Jun 25;12(6):e2486. doi:10.1002/mgg3.2486.
- Duncan ME, Purohit A, Economy KE, et al. Cardiac Complications of Pregnancy in desmoplakin Cardiomyopathy. JACC: Case Reports. 2023 Jun 21:16:101880. doi:10.1016/j.jaccas.2023.101880
- Cardiovascular Characteristics of Patients with Genetic Variation in desmoplakin (DSP) [Internet], [cited 2025 Jul 28]. Available from: https://www.mdpi.eom/2035-8148/12/1/3
- Taylor MRG, Slavov D, Ku L, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation. 2007; 115(10): 1244-5I. doi: 10.11 61/CIRCULATIONAHA. 106.646778
- McNair WP, Sinagra G, Taylor MRG, et al. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol. 2011 May 24;57(21):2160-8. doi:10.1016/j.jacc.2010.09.084.
- Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations | JACC [Internet], [cited 2025 Jul 28], Available from: https://www.jacc.org/doi/10.1016/jjacc.2018.08.2181
- Verdonschot JAJ, Vanhoutte EK, Claes GRF, et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum Mutat. 2020 Jun;41(6):1091-111. doi:10.1002/humu.24004.
- Tayal U, Prasad S, Cook SA. Genetics and genomics of dilated cardiomyopathy and systolic heart failure. Genome Medicine. 2017 Feb 22;9(1):20. doi:10.1186/s13073-017-0410-8
- Voinescu OR, lonescu Bl, Militaru S, et al. Genetic Characterization of Dilated Cardiomyopathy in Romanian Adult Patients. International Journal of Molecular Sciences. 2024 Jan;25(5):5. doi:10.3390/ijms25052562
- Akinrinade O, Ollila L, Vattulainen S, et al. Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy. European Heart Journal. 2015 Sep 7;36(34):2327-37. doi:10.1093/eurheartj/ehv253
- Nguyen TV, Tran Vu MT, Do TNP, et al. Genetic Determinants and Genotype-Phenotype Correlations in Vietnamese Patients With Dilated Cardiomyopathy. Circulation Journal. 2021 ;85(9): 1469-78. doi: 10.1253/circj.CJ-21-0077
- Ewans LJ, Minoche AE, Schofield D, et al. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis. Eur J Hum Genet. 2022 Oct;30(10):1121—31. doi:10.1038/s41431-022-01162-2.
- Long PA, Evans JM, Olson TM. Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2017 Sep;4(3):3. doi: 10.3390/jcdd4030011
- Pezzoli L, Pezzani L, Bonanomi E, et al. Not Only Diagnostic Yield: Whole-Exome Sequencing in Infantile Cardiomyopathies Impacts on Clinical and Family Management. Journal of Cardiovascular Development and Disease. 2022 Jan;9(1):1. doi:10.3390/jcdd9010002
- Mazzarotto F, Olivotto I, Walsh R. Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy. Cardiovasc Drugs Ther. 2020 Apr 1;34(2):241-53. doi:10.1007/s10557-020-06948-4
- Herkert JC, Abbott KM, Birnie E, et al. Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy. Genetics in Medicine. 2018 Nov 1 ;20(11):1374-86. doi:10.1038/gim.2018.9
- Pugh TJ, Kelly MA, Gowrisankar S, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genetics in Medicine. 2014 Aug 1; 16(8):601-8. doi:10.1038/gim.2013.204
- Helib K, Cicerchia M, Hathaway J, et al. Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients. Front Cardiovasc Med. 2023 Sep 19; 10:1254272. doi: 10.3389/fcvm.2023.1254272.
- Xiao L, Wu D, Sun Y, et al. Whole-exome sequencing reveals genetic risks of early-onset sporadic dilated cardiomyopathy in the Chinese Han population. Sci China Life Sci. 2022 Apr 1 ;65(4):770-80. doi: 10.1007/sl 1427-020-1951-4
- Linnér E, Czuba T, Gidlöf O, et al. Whole genome sequencing in early onset advanced heart failure. Sci Rep. 2025 Feb 5; 15:4306. doi: 10.1038/s41598-025-88465-8.
- Ben-Haim Y, Sangaralingam A, Pittman A, et al. Whole genome sequencing in the 100,000 Genomes project identifies a RYR2 variant associating with dilated cardiomyopathy and sudden unexpected death in the young. Europace. 2023 May 24;25(Suppl 1) :euad122.258. doi: 10.1093/europace/euad 122.258.
- Anastasiou V, Papazoglou AS, Gossios T, et al. Prognostic implications of genotype findings in non-ischaemic dilated cardiomyopathy: A network meta-analysis. Eur J Heart Fail. 2024 Oct;26(10):2155-68. doi:10.1002/ejhf.3403.
- Paldino A, De Angelis G, Merlo M, et al. Genetics of Dilated Cardiomyopathy: Clinical Implications. Curr Cardiol Rep. 2018 Aug 13;20(10):83. doi: 10.1007/s11886-018-1030-7
- Kasraian L, Railey J, Mehta C, Garvey MH. Stem Cell Treatment for Dilated Cardiomyopathy: A Review of Recent Scientific Advances. Georgetown Medical Review. 2024 Sep II ;8(1). doi: 10.52504/001 c. 123163
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [Internet], [cited 2025 Jul 28], Available from: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure#
- Dilated Cardiomyopathy And Therapeutic Follow-Up: Experience Of A Dedicated Heart Failure Clinic | Request PDF. Research- Gate. 2024 Oct 22. doi:10.1093/eurheartjsupp/suae036.199
- Lidington D, Fares JC, Uhl FE, et al. CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage. JACC Basic Transl Sci. 2019 Nov 27;4(8):940-58. doi:10.1016/j.jacbts.2019.07.00.
- Chen YJ, Chien CS, Chiang CE, et al. From Genetic Mutations to Molecular Basis of Heart Failure Treatment: An Overview of the Mechanism and Implication of the Novel Modulators for Cardiac Myosin. International Journal of Molecular Sciences. 2021 Jan;22(12):12. doi:10.3390/ijms22126617
- Day SM, Tardiff JC, Ostap EM. Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure. J Clin Invest. 132(5):e148557. doi:10.1172/JCI148557.
- O’Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). American Heart Journal. 1999 Jul 1; 138(1):78—86. doi: 10.1016/S0002-8703(99)70250-4
- Mahmaljy H, Yelamanchili VS, Singhal M. Dilated Cardiomyopathy. In: StatPearls [Internet]. Treasure Island (FL): Stat- Pearls Publishing; 2025 [cited 2025 Mar 4], Available from: http://www.ncbi.nlm.nih.gov/books/NBK441911/.
- Kooiker KB, Mohran S, Turner KL, et al. Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac Muscle. Circulation Research. 2023 Aug 18;133(5):430-43. doi:10.1161/CIRCRESAHA.123.322629
- Javed S, Halliday BP Precision therapy in dilated cardiomyopathy: Pipedream or paradigm shift? Camb Prism Precis Med. 2023;1:e34. doi:10.1017/pcm.2023.24.
- De Boer RA, Heymans S, Backs J, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). Eur J Heart Fail. 2022 Mar;24(3):406-20. doi:10.1002/ejhf.2414.
- Satoh M, Minami Y, Takahashi Y, et al. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. 2010 May;16(5):404-10. doi: 10.1016/j.cardfail.2010.01.002.
- Abstract We118: Phosphoglycerate Dehydrogenase Gene Therapy for Dilated Cardiomyopathy | Request PDF. ResearchGate. 2024 Oct 22. doi: 10.1161/res. 135.suppl_1 .We118
- Khan M, Yazaki K, Ishidoya Y, et al. Abstract Wb105: cBIN1 Gene Therapy Improves Left Ventricular Filling Pressure in a Canine Model of Ischemic Dilated Cardiomyopathy. Circulation Research. 2024 Aug 2;135(Suppl_1):AWe105-AWe105. doi:10.1161/res.135.suppl_1 .We105
- In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin | Genome Biology | Full Text [Internet], [cited 2025 Mar 26]. Available from: https://genomebiology.biomedcentral.com/articles/10.1186/s13059-024-03283-x
- Cas13b-mediated RNA targeted therapy alleviates genetic dilated cardiomyopathy in mice | Cell & Bioscience | Full Text [Internet], [cited 2025 Mar 26]. Available from: https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-023-01143-y
- Identification of a novel causative gene for dilated cardiomyopathy requiring heart transplantation and elucidation of the mechanism of protein homeostasis in cardiomyocytes. ResearchGate. 2024 Dec 31. doi:10.1254/jpssuppl.96.0_1-B-S02-1
- Kamdar F, Klaassen Kamdar A, Koyano-Nakagawa N, et al. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies. J Card Fail. 2015 Sep;21(9):761-70. doi: 10.1016/j.cardfail.2015.04.010.
- Recchia FA, Lionetti V. Animal models of dilated cardiomyopathy for translational research. Vet Res Commun. 2007 Aug;31 Suppl 1:35-41. doi:10.1007/s11259-007-0005-8.
Language: English
Page range: 64 - 73
Submitted on: Aug 15, 2025
Accepted on: Sep 26, 2025
Published on: Jun 16, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 K. Vitanova, R. Tzveova, T. Yaneva-Sirakova, M. Shumkova, I. Dimova, R. Kaneva, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.